Evidence map›Paper›PMID 24926856›Full record

Trial reportGenetic testing and molecular biomarkers2014

Genetic testing for the susceptibility to alcohol dependence: interest and concerns in an African American population.

Denise M Scott, Evaristus Nwulia, John Kwagyan, Gloria Cain, Vanessa J Marshall, Nnenna Kalu, Altovise Ewing, Robert E Taylor

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Genetic testing and molecular biomarkers, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genetic feedback for psychiatric conditions: Where are we now and where are we going.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Beliefs and Preferences for Medical Research Among African-Americans.Journal of racial and ethnic health disparities · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Denise M Scott1 Department of Pediatrics, Howard University , Washington, District of Columbia.
Evaristus Nwulia
John Kwagyan
Gloria Cain
Vanessa J Marshall
Nnenna Kalu
Altovise Ewing
Robert E Taylor
Howard University · USHoward University Hospital · USJohns Hopkins University · US

Funding

UVDM01RR010284 · NCRR · HOWARD UNIVERSITY · PI TAYLOR, WILLIAM ROBERT · 1996 to 2010
$17.4M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
PRENATAL ALCOHOL--EFFECTS ON CENTRAL DOPAMINE RECEPTOR SUBTYPESU24AA011898 · NIAAA · HOWARD UNIVERSITY · PI TAYLOR, ROBERT E · 1997 to 2002
$1.7M
NCRR NIH HHS M01-RR10284NIAAA NIH HHS AA014643NIAAA NIH HHS U24AA11898NIMHD NIH HHS G12 MD007597
6 · The paper itself

Abstract

backgroundThe search to identify genes for the susceptibility to alcohol dependence (AD) is generating interest for genetic risk assessment. The purpose of this study is to examine the level of interest and concerns for genetic testing for susceptibility to AD.

methodsThree hundred four African American adults were recruited through public advertisement. All participants were administered the Genetic Psycho-Social Implication (GPSI) questionnaire, which surveyed their interests in hypothetical genetic testing for AD, as well as their perception of ethical and legal concerns.

resultsOver 85% of participants were interested in susceptibility genetic testing; however, persons with higher education (p=0.002) and income (p=0.008) were less willing to receive testing. Perception of AD as a deadly disease (48.60%) and wanting to know for their children (47.90%) were the strongest reasons for interest in testing. Among those not interested in testing, the belief that they were currently acting to lower their risk was the most prevalent. The most widely expressed concern in the entire sample was the accuracy of testing (35.50%). Other notable concerns, such as issues with the method of testing, side effects of venipuncture, falsely reassuring results, and lack of guidelines on "what to do next" following test results, were significantly associated with willingness to receive testing.

conclusionAlthough an overwhelming majority of participants expressed an interest in genetic testing for AD, there is an understandable high level of methodological and ethical concerns. Such information should form the basis of policies to guide future genetic testing of AD.

Indexed as

Attitude to HealthGenetic TestingSurveys and QuestionnairesAdultAlcoholismBlack or African AmericanHumansMaleMiddle AgedSocioeconomic Factors

Identifiers

PMID24926856
PMCPMC4120651
OpenAlexW1973069567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.